Dianthus Therapeutics Inc
NASDAQ:DNTH
Dianthus Therapeutics Inc
NASDAQ:DNTH
Price:
107.56
USD
1.28%
Market Closed
Market Cap:
$5.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Dianthus Therapeutics Inc
NASDAQ:DNTH
|
US |
|
SSH Group Ltd
ASX:SSH
|
AU |
|
OSE Immunotherapeutics SA
F:6OP
|
FR |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
Snam SpA
MIL:SRG
|
IT |
|
P
|
Pampa Energia SA
F:9PAA
|
AR |
|
P
|
Procter & Gamble Co
F:PRG
|
US |
|
Colgate-Palmolive Co
NYSE:CL
|
US |
|
Tomra Systems ASA
OTC:TMRAF
|
NO |
|
F
|
Fortescue Ltd
XMUN:FVJ
|
AU |
|
Essilorluxottica SA
PAR:EL
|
FR |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IST:PENTA.E
|
TR |
|
C
|
Comcast Corp
XHAM:CTP2
|
US |
|
Grupa Pracuj SA
F:BP8
|
PL |
|
Hey-Song Corp
TWSE:1234
|
TW |
|
Horai Co Ltd
TSE:9679
|
JP |
|
Genting Singapore Ltd
SGX:G13
|
SG |
|
A
|
Ameriprise Financial Inc
F:A4S
|
US |
Multiples-Based Value
The Multiples-Based Value for Dianthus Therapeutics Inc (DNTH) under the Base Case is hidden
USD.
Compared with the current market price of 107.56 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
DNTH Multiples-Based Value
LOCKED